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Investigating the innate immune response mediators released in milk has manifold implications, spanning from elucidation of
the role played by mammary epithelial cells (MECs) in fighting microbial infections to the discovery of novel diagnostic markers
for monitoring udder health in dairy animals. Here, we investigated the mammary gland response following a two-step experi-
mental infection of lactating sheep with the mastitis-associated bacterium Streptococcus uberis. The establishment of infection
was confirmed both clinically and by molecular methods, including PCR and fluorescent in situ hybridization of mammary tis-
sues. Proteomic investigation of the milk fat globule (MFG), a complex vesicle released by lactatingMECs, enabled detection of
enrichment of several proteins involved in inflammation, chemotaxis of immune cells, and antimicrobial defense, including
cathelicidins and calprotectin (S100A8/S100A9), in infected animals, suggesting the consistent involvement of MECs in the in-
nate immune response to pathogens. The ability of MECs to produce and release antimicrobial and immune defense proteins
was then demonstrated by immunohistochemistry and confocal immunomicroscopy of cathelicidin and the calprotectin subunit
S100A9 onmammary tissues. The time course of their release in milk was also assessed byWestern immunoblotting along the
course of the experimental infection, revealing the rapid increase of these proteins in theMFG fraction in response to the pres-
ence of bacteria. Our results support an active role of MECs in the innate immune response of the mammary gland and provide
new potential for the development of novel andmore sensitive tools for monitoring mastitis in dairy animals.
Sheep mastitis is most frequently due to Gram-positive envi-ronmental pathogens, including Staphylococcus aureus, Staph-
ylococcus epidermidis, and Streptococcus uberis (1–3), together with
bacteria belonging to the class Mollicutes (including Mycoplasma
agalactiae, the agent of contagious agalactia). The typical infection
route is the teat canal, where microorganisms encounter the first
line of host defense (4, 5). The milking machine, in particular, is
considered to be detrimental, in that it induces teat end erosion
and impairs skin conditions, resulting in a higher level of coloni-
zation with environmental pathogens (6). During milking, the
sphincter muscles at the teat end open to let out the milk, and
about 2 h is needed for the canal to be completely reclosed (7).
During this time, mammary tissue is more exposed to invasion
and colonization by microbial pathogens. Such colonization can
result in infection (mild and acute) and, followed by inflamma-
tion of the mammary gland, develops into clinical disease. Clinical
mastitis is usually associated with an increase in breast tempera-
ture and with functional disorders of the mammary gland, ranging
from abnormalities in milk to complete agalactia (2). Microbial
invasion of the host can last for long periods of time, requiring
prolonged antibiotic therapy. Many microorganisms, including
Streptococcus uberis, can also cause subclinical infections that do
not lead to clinically evident manifestations, such as fever or swell-
ing of the mammary gland, or to detectable milk abnormalities.
These subclinical infections represent a serious problem for
breeders, since subclinically infected animals can go undetected
and act as pathogen reservoirs. Currently, a convenient and effec-
tive procedure to identify animals with subclinical mastitis is not
available. In addition to more time-consuming and cumbersome
procedures, such as the microbiological culture of milk, the pres-
ence of a mammary gland infection can be quickly evaluated by
using the milk somatic cell count (SCC), since this parameter is
commonly associated with inflammation (8–10). However, these
tests are known to possess only moderate sensitivity and specificity
(9, 11), since the increase in somatic cells is not exclusively depen-
dent on bacterial infections but can also be influenced by the pres-
ence of viral infections, animal age, lactation stage, level of milk
production, as well as various sources of stress, such as those
caused by vaccinations and other treatments (8, 12–17). More-
over, SCC tests performed without nuclear staining have demon-
strated a fair level of reliability in cattle but are subjected to a
higher level of error when applied to small ruminants (sheep and
goat). In fact, in small ruminants, milk secretion leads to the re-
lease of abundant amounts of cell debris in milk, and this debris is
enumerated as somatic cells. In addition, the small ruminant milk
production cycle is seasonal, and a physiological increase in the
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number of somatic cells is commonly observed at the end of lac-
tation. There is therefore a need to investigate and elucidate the
molecular mechanisms occurring during the establishment of a
microbial infection in the lactating mammary gland, in order to
identify new potential biomarkers suitable for the sensitive and
specific detection of subclinical infections in small ruminants,
which might also have potential for translation to other dairy an-
imals.
Recently, we investigated milk fat globules (MFGs) to study the
biology of the lactating cell and to evaluate the alterations occur-
ring in sheep naturally infected by the bacterial pathogen Myco-
plasma agalactiae (18). MFGs represent a suitable experimental
system with which to evaluate the dynamic changes occurring in
mammary epithelial cells (MECs) during infection. Indeed, MFGs
are a natural product that may be used to sample the assortments
of molecular networks that are activated within the lactating cell in
vivo. Using the MFG approach, we found that, upon exposure to a
bacterial pathogen, sheep lactating MECs release an assortment of
proteins and peptides involved in the innate immune defense
against pathogens, such as cathelicidin, S100 proteins, serum
amyloid A3, and lactoferrin, accompanied by a marked reduction
in proteins linked to the physiological pathways of lactation. No-
tably, alterations in the innate immune defense proteins were also
clearly evident in subclinically infected animals.
In general, analysis of mediators of innate immunity might
represent the ideal tool for detecting a subclinical infection, since
these come into play at early stages and are usually pathogen in-
dependent. In addition, their production from infected epithelial
cells and locally recruited immune cells can also take place at later
stages of infection. Therefore, identifying early immune media-
tors can generate useful information on potential biomarkers for
the development of mastitis detection strategies. While there is a
scarcity of molecular studies on sheep mastitis, recent reports on
bovine and caprine mastitis have provided a wealth of data that
might serve as a model for innate immunity against environmen-
tal pathogens in ewes (19–21). According to these findings, once a
Gram-positive pathogen enters into the mammary gland, its
pathogen-associated molecular patterns (PAMPs; i.e., its lipo-
teichoic acid) are recognized through activation of pattern recog-
nition receptors (PRRs; i.e., Toll-like receptor 2), triggering an
innate immune response in mammary tissues (5, 22, 23). As a
result, effector molecules that include antimicrobial peptides
(AMPs) and acute-phase proteins (APPs) are produced and re-
leased. In this respect, MECs are expected to play a pivotal role
from the early stages of innate immunity (24–29).
Efforts are required to elucidate the molecular and cellular
mechanisms that influence innate immunity in sheep and to clar-
ify the role played by the secreting mammary epithelium. Indeed,
data on how innate immunity is orchestrated in sheep mammary
gland tissues can contribute to the development of effective and
appropriate treatment protocols aimed at limiting colonization
and infections and to great decreases in the impact of mastitis in
the dairy sheep industry.
The aim of this study was to gain a deeper knowledge of the
events taking place in the infected mammary tissue of sheep and to
clarify the role played by MECs by applying MFG proteomics and
a combination of molecular and immunological techniques. In
addition, the ability of S. uberis to establish a mammary infection
in sheep was demonstrated. Protein expression profiles of MECs
were assessed by means of two-dimensional (2D) difference-in-
gel electrophoresis (DIGE) and SDS-PAGE separation, followed
by liquid chromatography-tandem mass spectrometry (GeLC-
MS/MS) of milk fat globule-associated proteins, revealing the up-
regulation in infected animals of a number of proteins involved in
the innate immune response against pathogens. Two of these,
S100A9 and cathelicidin, were then assessed by immunological
methods for their cellular origin and kinetics of release in milk.
Useful insights into the contribution of lactating MECs to fighting
bacterial infections were obtained, as was an indication of several
molecules with the potential to be candidates for use in the imple-
mentation of novel strategies for mastitis detection.
MATERIALS AND METHODS
Animal infection and sample collection. Five Sarda sheep in midlacta-
tion with no history of S. uberis infection were chosen for inclusion in the
study. Experimental infections were carried out at the Istituto Zoopro-
filattico Sperimentale della Sardegna (IZS). Here, sheep were confined
separately from each other and subsequently tested to assess their suitabil-
ity (fitness) for the experimental procedures, as described previously (3).
All animal-related procedures used in this study were performed in accor-
dance with the policies of IZS. Experimental infection of sheep was per-
formed in the context of a research project entitled “I geni di resistenza e
il ruolo dei mediatori dell’infiammazione nelle mastiti ovine,” identifica-
tion (ID) number IZS SA 002/07, funding program Ricerca Corrente
2007. The project was approved (including ethical approval), financed,
and authorized by the Italian Ministry of Health and the IZS. The S. uberis
strain used for experimental infection was isolated in Sardinia, Italy, from
a sheep with clinical mastitis. Before inoculation, the teat ends were
cleaned with disinfectant. Four clinically healthy sheep were inoculated
twice and kept in separate, contiguous sheds; a control animal was not
inoculated, and it was maintained in a contiguous shed during the infec-
tion experiment. The two S. uberis inoculations were performed a week
apart, and the inocula were administered into the teat cistern of the left
half of the udders of four sheep with a syringe. The right half of the udders
was inoculated with sterile phosphate-buffered saline (PBS) as a control.
During experimental infection, milk was collected daily from both teats of
each sheep. Milk samples were subjected to bacteriological culture and
PCR analysis for the detection of S. uberis. Six days after the second inoc-
ulation, all animals were sacrificed and subjected to necropsy. Mammary
tissue samples were collected during necropsy and immediately frozen at
80°C.
Histopathological grading. The degree of tissue injury was assessed
on hematoxylin-eosin-stained slides and was based on a semiquantitative
grading system (30). Histopathological grading was carried out on four
animals (three experimentally infected animals and one control animal),
since one experimentally infected animal developed agalactia within 24 h
after the second bacterial inoculation. Both infected and uninfected half
udders were graded for each subject. For each half udder, 5 random mi-
croscopy fields were examined at 20 magnification, and lesions were
graded with a scoring grid based on estimation of epithelial desquamation
and leukocytic infiltrates (neutrophils, macrophages, and lymphocytes),
with scores indicating the presence or absence of lesions, the abundance of
the different cell types, and the extent of the lesions, as follows: 1, absent;
2, rare; 3, moderate; 4, severe. Fibrosis in particular was useful to assess if
the experimental animals had previously been exposed to mastitis.
Extraction of MFGPs. MFG proteins (MFGPs) were extracted from
raw milk as described previously (30–32). Briefly, milk samples were cen-
trifuged to separate the cream fraction containing MFGs from the remain-
ing protein fraction of milk. In order to eliminate highly abundant milk
proteins, the cream was washed twice in phosphate-buffered saline and
once in triple-distilled water. Subsequently, the MFGs were subjected to
crystallization, to mechanical homogenization, and to heating in order to
separate the protein fraction from the lipid fraction. The protein concen-
tration was determined with a 2D Quant kit (GE Healthcare, Uppsala,
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Sweden), and the quality of the extracts was checked by resuspension in
Laemmli buffer (33), separation using 10% acrylamide gels, and staining
with SimplyBlue SafeStain (Invitrogen, Carlsbad, CA). The samples were
stored at20°C until analysis.
SDS-PAGE and 2D DIGE. Proteins extracted from MFGs (MFGPs)
were analyzed by 2D DIGE, as described previously (18). Sixty micro-
grams of proteins was labeled with 400 pmol of N-hydroxysuccinimidyl
ester of cyanine dyes Cy3 (preinfection) and Cy5 (postinfection) (GE
Healthcare, Uppsala, Sweden). Equal amounts of all experimental sam-
ples were properly combined to create the internal pooled standard, which
was labeled with the Cy2 cyanine dye. The labeled protein samples were
conveniently mixed and brought to the final rehydration volume with
immobilized pH gradient (IPG) buffer (GE Healthcare) and Destreak
rehydration solution (GE Healthcare, Uppsala, Sweden). The samples
were applied to 24-cm IPG strips (pH 3 to 11, nonlinear; GE Healthcare,
Uppsala, Sweden) by passive rehydration overnight at room temperature.
After rehydration, IPG strips were run together on an Ettan IPGphor 3
apparatus (GE Healthcare, Uppsala, Sweden) using a gradient voltage
increase for a total of about 90,000 V h. Afterwards, the strips were re-
duced and alkylated through the process of equilibration, subjected to
second-dimension SDS-PAGE, and digitized with a Typhoon 9400 scan-
ner (GE Healthcare, Uppsala, Sweden) as described previously (18). All
images were analyzed with a DeCyder batch processor and differential
in-gel analysis (DIA) modules (GE Healthcare, Uppsala, Sweden) for the
detection and matching of spots, while statistical analysis of protein-level
changes was performed with the DeCyder biological variation analysis
(BVA; v.6.5) module. The results related to preinfection and postinfection
samples were compared by calculation of fold changes and statistically
evaluated by one-way analysis of variance (ANOVA) with the DeCyder
BVA module. To minimize the number of false-positive results, the false
discovery rate (FDR) was applied to the analysis. Protein spots were se-
lected as differentially expressed if they showed a change in expression of
2-fold with a statistically significant variation (P 0.05). The DeCyder
extended data analysis (EDA) module was used for performing cluster
analysis by principal component analysis (PCA).
Tandemmass spectrometry.The proteins differentially expressed ac-
cording to the 2D DIGE analysis were subjected to identification using
preparative 2D polyacrylamide gels. For optimum matching with the 2D
DIGE maps, 24-cm IPG strips with a pH gradient (3-11NL; GE Health-
care, Uppsala, Sweden) were used. All strips were rehydrated with 300 g
of protein, focused, and subjected to the second dimension of electropho-
resis. After electrophoresis, all gels were stained with SimplyBlue SafeStain
(Invitrogen, Carlsbad, CA), and images were acquired by a ImageScanner
III apparatus (GE Healthcare, Uppsala, Sweden). Matching between 2D
DIGE and 2D polyacrylamide gels was performed using Image Master 2D
Platinum (v.6.0.1) software (GE Healthcare, Uppsala, Sweden). Differen-
tially expressed spots detected by 2D DIGE analysis were excised,
destained, and subjected to tryptic digestion. Peptide mixtures were acid-
ified, dried, and then resuspended in formic acid. Protein identification
was performed on a XCT Ultra 6340 ion trap equipped with a 1200 high-
pressure liquid chromatography system and a chip cube (Agilent Tech-
nologies, Palo Alto, CA), as described previously (34).
MGF files obtained by LC-MS/MS analysis were analyzed by Proteome
Discoverer (v.1.3; Thermo Scientific), which used an in-house Mascot
server (v.2.3; Matrix Science) for identification of proteins in the updated
UniProt database (release 2012_01), the Mammalia taxonomy, and the
following search parameters: precursor mass tolerance, 300 ppm; frag-
ment mass tolerance, 0.6 Da; charge states, 2, 3, and  4; trypsin
enzyme; two missed cleavages; cysteine carbamidomethylation as the
static modification; and N-terminal glutamine conversion to pyroglu-
tamic acid and methionine oxidation as dynamic modifications.
Label-free quantification. This analysis was performed on two prein-
fection samples (samples obtained on day 0 [D0]) and on two postinfec-
tion samples (samples obtained on the third day after the second infection
[3DIIi]) as described previously (18). For each sample, 30 g of protein
was separated by SDS-PAGE using 4 to 20% acrylamide gradient gels and
stained with SimplyBlue SafeStain (Invitrogen, Carlsbad, CA), and 25
slices were cut from each lane. All gel slices were subjected to bleaching,
reduction, alkylation, digestion with trypsin, and recovery of the peptides
from the gel before LC-MS/MS analysis, as described previously (30).
Identification of peptides was performed on an LTQ-Orbitrap Velos
mass spectrometer (Thermo Scientific, San Jose, CA) interfaced with an
UltiMate 3000 RSLCnano LC system (Dionex [now part of Thermo Sci-
entific], Sunnyvale, CA), as described previously (35). Briefly, after load-
ing, the peptide mixtures were concentrated and desalted on a trapping pre-
column and separated on a 75-m (inner diameter) by 25-cm C18 column
(Acclaim PepMap rapid separation liquid chromatography [RSLC] C18 col-
umn [75-m by 15-cm nanoViper system; particle size, 2 m; 100 Å]; Di-
onex). Peptide mixtures from gel slices were subjected to 60-min runs. The
LTQ-Orbitrap Velos mass spectrometer was set up in a data-dependent
MS/MS mode under direct control of Xcalibur software (v.1.0.2.65 SP2),
where a full-scan spectrum was followed by tandem mass spectra (MS/MS).
Peptide ions were selected as the 10 most intense peaks (top 10) of the previ-
ous scan. Higher-energy collisional dissociation (HCD) was chosen for frag-
mentation with nitrogen as the collision gas. The raw files generated by the
LTQ-Orbitrap mass spectrometer were analyzed on a Proteome Discoverer
platform (v.1.4; Thermo Scientific, Bremen, Germany) to obtain protein
identifications. All peak lists were processed against the UniProt database
(release 2013_05) with the following search parameters: Mammalia as the
taxonomy; peptide tolerance, 10 ppm; MS/MS tolerance, 0.02 Da; charge
states,2,3, and 4; cysteine carbamidomethylation as the static modifi-
cation; N-terminal glutamine conversion to pyroglutammic acid and methi-
onine oxidation as dynamic modifications; trypsin enzyme; and allowing up
to two missed cleavages. To evaluate peptide validation, the percolator algo-
rithm was used. For label-free quantification, all peptides with a q value of
0.01 and a peptide rank of 1 were included (36). Trypsin and skin keratins
were excluded from the final protein list obtained by Proteome Discoverer.
Data analysis.Label-free quantification based on spectral count (SpC)
values was used as a semiquantitative measure to evaluate protein abun-
dance and to compare the expression of the same protein among different
samples, as described previously (18, 31). Only the proteins with the high-
est number of unique peptides and SpCs were selected between different
homologue proteins present in each sample. The normalized spectral
abundance factor (NSAF) and the SpC log ratio (RSC) were used to express
protein abundance and the fold change between different conditions, re-
spectively. NSAF and RSC were calculated according to the methods de-
scribed by Old et al. (37) and Zybailov et al. (38), respectively. NSAF
values, subdivided for cellular component and biological process catego-
ries, were used to compare the expression of diverse proteins among sam-
ples. A two-tailed t test with a 95% confidence level was used to evaluate
the statistical significance of abundance categories for cellular component
and biological processes between different conditions, while the beta-
binomial test was performed to identify differentially expressed proteins
according to the method described by Pham et al. (39). P values were
corrected by the FDR.
Western immunoblotting. After extraction of MFGPs, samples were
resuspended in lysis buffer, loaded in 18% acrylamide gels, and subjected
to electrophoresis for separation of proteins. Afterwards, proteins were
transferred to nitrocellulose membranes (GE Healthcare, Uppsala, Swe-
den) at 100 V for 90 min using a Trans-Blot cell apparatus (Bio-Rad,
Hercules, CA). Western immunoblotting was performed using a SNAP
i.d. protein detection system (EMD Millipore) following the instructions
recommended by the manufacturer. Primary antibodies were rabbit anti-
human S100A9 (Sigma-Aldrich, St. Louis, MO) and rabbit anti-human
cathelicidin AMP (CAMP; Sigma-Aldrich, St. Louis, MO). An anti-rabbit
IgG (whole molecule)-peroxidase produced in goat (Sigma-Aldrich, St.
Louis, MO) was used as the secondary antibody. For the detection of the
signal, the chemiluminescent peroxidase substrate (Sigma-Aldrich, St.
Louis, MO) was used, and blot images were acquired with a VersaDoc MP
4000 system (Bio-Rad, Hercules, CA).
Addis et al.
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PCR and probe design. DNA extraction was carried out from milk
and mammary tissue using a DNeasy blood and tissue kit (catalog no.
69506; Qiagen) according to the manufacturer’s instructions. PCR was
performed using primers Ub F and Ub R, designed on two variable regions
of the S. uberis 23S rRNA with the following sequences: 5=-GCGAAGTG
GGACATAAAGTTA-3= (Ub probeF) and 5=-GCGGCTGTCATCGCTG
A-3= (Ub probeR). PCRs were performed in a GeneAmp PCR system 9700
(Applied Biosystems) as follows: an initial denaturation step (95°C for 2
min), followed by 30 cycles of denaturation (95°C for 1 min), annealing
(56°C for 1 min), and extension (72°C for 1 min). A final extension step at
72°C for 10 min was included. PCR products of 1,446 bp were observed
upon agarose gel electrophoresis according to standard procedures. For
hybridization, two S. uberis-specific biotinylated oligonucleotide probes
were designed on two variable regions of the 23S rRNA, using primers Ub
probeF (5=-biotin-GCGAAGTGGGACATAAAGTTA-3=) and Ub probeR
(5=-biotin-GCGGCTGTCATCGCTGA-3=). Two new sets of universal
primers external to the probes were also designed: set 1, Ub-F-probeF
(5=-GGCGAGCGAAACGGCAGGAG-3=) and Ub-R-probeF (5=-TTTCG
CGTGTCTCGCCGTACT-3=) (product size, 182 bp) and set2, Ub-F-
probeR (5=-TGAGCTGTGATGGGGAGCGAAA-3=) and Ub-R-probeR
(5=-GGGCAGGCGTCACCCCCTAT-3=) (product size, 300 bp). Probes
and primers were designed by using the nucleotide sequences of the 23S
rRNA of several bacterial strains collected from the GenBank database and
aligned using ClustalW software. To assess the specificities of the probes,
PCR-dot blot assays were performed on the DNAs isolated from the fol-
lowing microorganisms: Streptococcus dysgalactiae 4065, Streptococcus
agalactiae 4066, Enterococcus faecium 3885, Enterococcus faecalis 4063,
Streptococcus bovis 1167, Streptococcus uberis 4064, Staphylococcus simu-
lans, Staphylococcus aureus, Staphylococcus chromogenes, Staphylococcus
epidermidis, Staphylococcus aureus Oxford, Enterococcus faecalis (wild
strain), Streptococcus uberis (strain used in the experimental infection).
Genomic DNA extraction was carried out from 24-h cultures of each
bacterial species using a DNeasy blood and tissue kit (catalog no. 69506;
Qiagen) according to the manufacturer’s instructions. The DNAs were
amplified using the two new sets of universal primers. The PCRs were
performed in a GeneAmp PCR system 9700 (Applied Biosystems) with an
initial denaturation step (94°C for 5 min), followed by 40 cycles of dena-
turation (94°C for 1 min), annealing (60°C for 1 min), and extension
(72°C for 1 min). A final extension step at 72°C for 10 min was included.
Amplicons of the expected sizes were purified from a 2% agarose gel using
a QIAquick gel extraction kit (catalog no. 28704; Qiagen). Dot blot hy-
bridization assays using specific Ub probeF or Ub probeR probes were
used in combination with PCRs for validation of the probe specificity.
In situ hybridization. Serial sections of sheep mammary glands were
probed for in situ detection of Streptococcus uberis using the biotin-con-
jugated specific probes described above, and the signal was revealed with
streptavidin-Alexa Fluor 555 conjugate (Invitrogen). Three-micrometer
sections were mounted on SuperFrost slides, deparaffinized, and rehy-
drated according to standard histologic methods. A pepsin digestion
(0.8% in 0.2 N HCl solution) was performed at 37°C for 30 min in Tris-
buffered saline (TBS; 20 mM Tris-HCl, 150 mM NaCl, pH 7.5). The sec-
tions were subjected to a postfixation step by incubation in an alcohol
ascending scale (from 50% to 98%) and air dried. The sections were in-
cubated at 55°C for 2 h with 200 l of prehybridization solution (50% of
Hybridization Solution II [43% deionized formamide, 7% nuclease-free
water]; Fluka). The prehybridization solution was replaced with 200l of
hybridization solution containing 1 nM Ub probeF, and the slides were
incubated overnight at 55°C. Stringent washes were then performed using
2, 1, and 0.5 SSPE (1 SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and
1 mM EDTA [pH 7.7]) at room temperature for 5 min each time and 0.1
SSPE at 50°C for 30 min. The sections were washed with TBS-Tween
(TBS-T; 20 mM Tris-HCl, 150 mM NaCl, pH 7.5, 0.05% Tween 20), and
the blocking of nonspecific sites was performed by incubation with 2%
bovine serum albumin in TBS-T for 1 h at 37°C. The signal was revealed by
incubating for 45 min in the dark at room temperature with streptavidin-
Alexa Fluor 555 conjugate (Invitrogen), and the nuclei were counter-
stained with Hoechst (Sigma) for 5 min. The slides were washed with
Milli-Q water, mounted with an aqueous medium, and then examined in
a confocal microscope (Leica TCS SP5). Images were captured and pro-
cessed with LAS AF Lite application software.
Immunohistochemistry. After euthanasia, mammary tissue samples
were collected from both inoculated and uninoculated half udders. A
portion of each sample was fixed in 10% paraformaldehyde in PBS, pro-
cessed through graded concentrations of alcohol and xylene, and embed-
ded in paraffin wax. Tissues were dewaxed and rehydrated, and endoge-
nous peroxidase activity was blocked by incubation with 0.3% hydrogen
peroxide in PBS for 30 min. As primary antibodies, rabbit anti-S100A9
(Sigma-Aldrich, St. Louis, MO), rabbit anti-CAMP (anti-cathelicidin;
Sigma-Aldrich, St. Louis, MO), and antipancytokeratin (Dako) antibod-
ies were applied as described by the manufacturers. To reveal antigens that
reacted with primary antibodies, a Histostain-Plus kit (diaminobenzi-
dine, broad spectrum; Invitrogen, Carlsbad, CA) was used. The sections
were then incubated with 3,3=-diaminobenzidine tetrahydrochloride (In-
vitrogen, Carlsbad, CA) and lightly counterstained with hematoxylin. Im-
ages of all sample tissues were visualized and obtained with a Nikon
Eclipse 80i microscope with a Nikon DS-Fi1 camera (Nikon Instruments
Inc., Melville, NY).
Immune colocalization. For immune colocalization analysis, the fol-
lowing antibodies were used: fluorescein isothiocyanate (FITC)-labeled
anti-cytokeratin 7 (EMD Millipore), FITC-labeled antineutrophil (7/4;
(Abcam, Cambridge, MA), FITC-labeled anti-F4/80 (BM8; Abcam, Cam-
bridge, MA), anti-S100A9 (Sigma-Aldrich, St. Louis, MO), and anti-
CAMP (anti-cathelicidin; Sigma-Aldrich, St. Louis, MO). In these exper-
iments, Alexa Fluor-conjugated secondary antibodies (Invitrogen,
Carlsbad, CA) were used for the detection of S100A9 and CAMP. Images
were acquired using a Leica TCS SP 5 confocal microscope (Leica Micro-
systems, Germany) and processed using LAS AF Lite application software
developed by Leica Microsystems CMS GmbH for contrast and brightness
adjustment. Negative controls prepared by omission of primary antibodies
did not show any FITC fluorescence under the conditions described above.
RESULTS
Experimental infection of sheep with S. uberis. The experimen-
tal infection was carried out on four animals, while a fifth animal
was not inoculated and served as a negative control. Figure 1 illus-
trates the experimental infection timeline. Preinfection milk sam-
ples were collected from all five animals (D0) as a reference to
FIG 1 Timeline of experimental infection: sample collection, S. uberis inoculation, and animal sacrifice and necropsy.
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enable evaluation of the changes induced upon infection with S.
uberis. Following administration of 1 106 CFU of S. uberis to a
single half udder (left half udder) and of the same volume of phys-
iological saline into the right half udder of four ewes, none of the
inoculated animals showed clinical symptoms of mastitis. The an-
imals were apparently healthy, and there were no evident altera-
tions in milk appearance or quantity. After 6 days, the same half
udders were inoculated with 2 107 CFU of S. uberis in order to
induce acute mastitis. At day 2 after the second infection (2DIIi),
udder swelling, rubor, calor, dolor, and reduction of milk volumes
were observed in the infected half udder, while the contralateral
half udders infused with saline did not show any visible alteration.
One of the ewes developed agalactia in the infected half udder,
while the neighboring half did not show clinical signs. Bacterio-
logical analysis of milk revealed the presence of S. uberis by the
second day of the second infection (2DIIi) only in the infected half
udder of all animals, and S. uberis was then detected over the
whole course of infection. The control animal remained clinically
healthy for the whole experimental period.
Macroscopic examination of half udders from all animals was
performed at necropsy 12 days after the first inoculation. This
analysis showed lesions due to acute purulent mastitis in the in-
fected half udders, while the uninfected halves showed no obvious
signs of inflammation. All infected animals showed an increase in
the volume of the supramammary lymph nodes of the inoculated
half udder compared to the volume of the supramammary lymph
nodes of the uninoculated one. The control animal was found to
be completely free of lesions in all observed sections. Microscopic
examination and histopathological grading of mammary tissues
highlighted a clear difference between infected and uninfected
udder halves. In fact, the latter appeared to be structurally similar
to the control udder, showing an intact epithelium of an organ in
full lactation. The alveolar lumens were free of exfoliated epithelial
cells or immune cells. The intra-alveolar wall displayed a normal
thickness, without edema, cellular exudates, or signs of infection.
On the contrary, samples from the infected half udders manifested
clear indications of acute flogosis, showing traits of degeneration
from medium to severe, with necrosis and desquamation affecting
both alveolar tubular epithelia. A cellular exudate was present
within alveoli and mainly constituted neutrophilic granulocytes,
and macrophages were found in the lower portion, indicating an
acute innate immune response to the presence of bacteria (Fig. 2).
Occasionally, minor foci of lymphoplasmacellular mastitis were
observed, but these were completely irrelevant in the observed
picture of acute purulent mastitis. These observations were con-
firmed by the histopathological grading and the final score ob-
tained, revealing a clear picture of mastitis in the infected half
udders and a clear picture of normality in the uninfected ones
(Table 1).
Alterations induced in the MFGP profile by acute bacterial
infection. MFG proteins (MFGPs) were investigated as an indica-
tor of the alterations occurring in MECs upon S. uberis infection.
FIG 2 Histopathological grading. Representative hematoxylin-eosin-stained sections of tissue from control and experimentally infected sheep are shown. The
tissues of the control sheep and uninoculated half udders of infected sheep are histologically normal. Inoculated half udders show intra-alveolar neutrophils
(solid arrow) and signs of degeneration of the secretory epithelium (dashed arrows). Magnifications,200.
TABLE 1 Histopathological grading
Group and sheep
Histopathological gradea
Epithelial
desquamation
Neutrophilic
infiltrate
Macrophagic
infiltrate
Lymphocitic
infiltrate Fibrosis
Control, sheep A 1 1 1 1 3
Infected udder halves
Sheep B 1 1 1 1 2
Sheep C 1 1 1 1 2
Sheep D 1 2 1 1 2
Mean 1 1 1 1 2
Uninfected udder halves
Sheep B 4 3 3 1 2
Sheep C 4 3 3 1 2
Sheep D 3 3 3 2 2
Mean 4 3 3 1 2
a The scores attributed upon microscopic examination of mammary tissues are reported as follows: 1, absent; 2, rare; 3, moderate; 4, severe.
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Only three infected animals were studied, since an animal devel-
oped agalactia within 24 h after the second bacterial inoculation.
With the aim of reducing individual variations to a minimum and
of maximizing detection of alterations specifically induced by S.
uberis, MFGP expression was evaluated by comparing milk sam-
ples obtained at D0 with milk from the same animals and half
udders obtained at 3DIIi (Fig. 3). Visible alterations in the total
protein profile were clearly induced by infection. These were sim-
ilar for the three infected animals, with numerous overabundant
proteins detected at different molecular masses, while the MFGPs
of the control animal remained unaffected.
To investigate the nature and intensity of these alterations, the
same samples were subjected to 2D DIGE analysis. Figure 4 re-
ports a representative 2D DIGE map. Statistically significant dif-
ferences in expression were detected for numerous proteins,
which were subjected to identification by LC-MS/MS. In total, 28
differential proteins were identified between samples collected be-
fore and after infection; of these, 16 proteins were overexpressed
and 15 were underexpressed in the presence of mastitis (Fig. 4;
Table 2).
The proteins overexpressed in milk samples collected from
mastitic half udders were mainly involved in (i) immune func-
tion, inflammation, and host defense, such as S100 proteins
(S100A9 and S100A11), cathelicidin, antimicrobial peptides,
and lactotransferrin; (ii) vesicular trafficking, such as annexin
and actin; and (iii) lipid metabolism, such as fatty acid-binding
proteins. Conversely, underexpressed proteins were mostly in-
volved in the physiological functions of the MFG, such as bu-
tyrophilin, lactadherin, adipophilin, and xanthine dehydroge-
nase/oxidase. Other underexpressed proteins included various
enzymes, such as triosephosphate isomerase, dehydrogenase/
reductase member 1, peroxiredoxin 6, and cell death-inducing
DNA fragmentation factor alpha (DFFA)-like effector A, and
several milk proteins, such as alpha-S1-casein, beta-casein, and
kappa-casein. PCA of all differentially expressed spots pro-
duced a separate clustering of the samples collected at D0 and at
3DIIi, demonstrating their statistically significant divergence.
To integrate the 2D DIGE approach and to compensate for
its limitations in analysis of liposoluble and low-abundance
proteins, a GeLC-MS/MS analysis was also carried out. In total,
849 unique proteins were identified and assessed for their rel-
ative abundance by a label-free quantitative approach (37). The
detailed list of all protein identifications is reported in File S1 in
the supplemental material. A total of 389 proteins showed a
statistically significant (P 0.05) difference in abundance of at
FIG 3 SDS-PAGE of sheep MFGPs before and after infection with S. uberis.
The image illustrates a representative gel of all proteins extracted from MFGs
isolated from the milk of all animals before infection (D0) and 3 days after the
second inoculation (3DIIi). Lane M, molecular mass markers.
FIG 4 Representative 2D DIGE profile of MFGPs from sheep before (green) and after (red) infection with S. uberis. An overlay image of representative MFGP
profiles obtained before (green) and after (red) infection with S. uberis is shown. Yellow spots result from the superimposition of red and green signals and
indicate similar levels of protein expression. Spots showing statistically significant differences are circled, and identities according to MS analysis are reported in
Table 2. MW, molecular weight (molecular weights are given in thousands).
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least 1.5 RSCs after S. uberis infection. Among these, 106 under-
went a statistically significant increase and are listed in Table 3.
In agreement with the DIGE results, a number of proteins that
increased upon infection were involved in innate immune re-
sponse processes and had direct or indirect antimicrobial activity.
These included lactotransferrin, cathelicidins, the calprotectin
subunits S100A9 and S100A8, myeloperoxidase, complement
C3, haptoglobin, immune cell-related proteases, pentraxin-related
protein PTX3, neutrophil cytosolic factors, serotransferrin, and bac-
tericidal permeability-increasing protein. Figure 5 illustrates their
normalized spectral abundance factors before and after infection.
Several other proteins had roles in inflammatory or immune re-
sponse processes. Significantly increased upon infection were also the
cytoskeletal proteins vimentin, myosins, actins, actin-related pro-
teins, tropomyosins, tubulins, annexins, profilins, coronins, and
tensins, many of which are involved in vesicular trafficking (Table 3;
see File S1 in the supplemental material).
LocalizationofS100A9andcathelicidin inmammary tissues.
According to the results obtained in this work and the observa-
tions that emerged in a previous study on natural infection by
Mycoplasma agalactiae (18), cathelicidins and the calprotectin
subunits S100A9 and S100A8 are among the proteins undergoing
the highest increase upon bacterial infection of mammary tissues.
In order to investigate their cellular origin and to gain insights into
the validity of the MFG proteomic model to assess the contribu-
tion of MECs to innate immune defense responses, mammary
TABLE 2 MFGPs showing statistically significant differences in abundance after S. uberis infection according to 2D DIGE
Protein function and Ng Identified protein Accession no.a Species Scoreb QMc
%
coveraged Avg ratioe ANOVAf
Inflammation and host
defense
2 Lactotransferrin Q5MJE8 Ovis aries 1,798 115 47 62.89 0.0015
25 Myeloid antimicrobial peptide
(cathelicidin family)
P79360 Ovis aries 432 19 47 25.42 0.024
24 Protein S100A9 P28783 Bos taurus 177 5 6 9.33 0.010
23 Cathelicidin 1 P54230 Ovis aries 378 22 50 13.15 0.016
27 Protein S100A11 P28783 Bos taurus 125 3 5 8.82 0.029
Cytoskeletal proteins
10 Annexin A3 Q3SWX7 Bos taurus 968 52 37 98.80 0.0097
14 Annexin AI P46193 Bos taurus 1328 35 60 82.84 0.015
13 Annexin AI P46193 Bos taurus 1438 46 59 54.96 0.010
12 Annexin AI P46193 Bos taurus 1467 43 58 43.07 0.021
11 Annexin A3 Q3SWX7 Bos taurus 1120 56 39 18.08 0.022
9 Actin, cytoplasmic 2 P63260 Mus musculus 1242 83 62 16.65 0.0087
8 Actin P60712 Bos taurus 496 38 27 4.93 0.029
Proteins involved in lipid
metabolism and
MFG secretion
26 Fatty acid-binding protein Q6S4N9 Capra hircus 691 62 66 17.04 0.0047
28 Butyrophilin subfamily 1 member A1 A3EY52 Capra hircus 399 10 15 9.33 0.002
4 Butyrophilin subfamily 1 member A1 A3EY52 Capra hircus 165 4 5 5.73 0.040
19 Butyrophilin subfamily 1 member A1 A3EY52 Capra hircus 409 12 17 5.67 0.039
7 Adipose differentiation-related protein A6ZE99 Ovis aries 364 11 20 5.01 0.024
5 Adipose differentiation-related protein A6ZE99 Ovis aries 623 44 27 4.74 0.024
6 Lactadherin Q95114 Bos taurus 496 25 17 4.64 0.035
1 Xanthine dehydrogenase/oxidase P80457 Bos taurus 819 29 11 3.58 0.0046
Enzymes
22 Triosephosphate isomerase Q5E956 Bos taurus 347 5 15 8.36 0.017
15 Dehydrogenase/reductase (SDR family) member 1 Q2KIS4 Bos taurus 792 61 41 6.40 0.017
21 Peroxiredoxin 6 O77834 Bos taurus 226 7 26 5.90 0.024
16 Cell death-inducing DFFA-like effector a A4FUX1 Bos taurus 161 5 13 4.15 0.028
Proteins involved in
folding, 3
70-kDa heat shock protein Q53GZ6 Bos taurus 125 3 5 6.37 0.020
Milk proteins
29 Lactoglobulin beta P02754 Bos taurus 157 7 56 8.66 0.021
18 Alpha-S1-casein P04653 Ovis aries 717 40 49 18.90 0.036
17 Beta-casein P33048 Capra hircus 301 20 27 15.54 0.001
20 Kappa-casein P02669 Ovis aries 268 12 28 6.65 0.017
a Accession number in the Uniprot database.
b The score represents the probability that the observed match between the experimental data and mass values calculated from a candidate peptide sequence is a random event.
c QM, queries matched, indicating the number of matched peptides in the database search.
d Percent coverage of the matched peptide in relation to the full-length sequence.
e Average ratio between 3DIIi and D0 samples.
f By one-way ANOVA (P 0.05).
g N, spot number in Fig. 4.
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tissues collected from all animals at necropsy were evaluated by
immunohistochemistry (IHC). Figure 6 reports the results ob-
tained when mammary tissues were probed with antibodies
against the calprotectin subunit S100A9 and cathelicidin. Anti-
pancytokeratin antibodies were used to highlight epithelial cells
and to obtain specific MEC staining.
TABLE 3 MFGPs showing a statistically significant increase in
abundance after S. uberis infectiona
Accession no.b Description RSC
Q6ECI6 Integrin beta-2 5.85
P05164 Myeloperoxidase 5.65
Q3SWX7 Annexin A3 5.49
P02544 Vimentin 5.23
P21333 Filamin A 5.18
Q92176 Coronin 1A 5.07
Q258K2 Myosin 9 4.88
P28783 Protein S100A9 4.84
Q1JPB0 Leukocyte elastase inhibitor 4.79
P20000 Aldehyde dehydrogenase, mitochondrial 4.33
P20700 Lamin B 4.14
Q8SPQ0 Chitinase-3-like protein 1 4.10
P27214 Annexin A11 4.09
O46522 Cytochrome b245 heavy chain 4.02
P47843 Solute carrier family 2, facilitated glucose
transport 3
3.91
Q29477 Lactotransferrin 3.85
Q2UVX4 Complement C3 3.81
P11979 Pyruvate kinase isozyme M1/M2 3.67
O75367 Core histone macro-H2A.1 3.58
B6E141 Haptoglobin 3.58
Q8VEK3 Heterogeneous nuclear ribonucleoprotein U 3.58
Q9XSJ4 Alpha-enolase 3.54
A0A1F3 L-Lactate dehydrogenase A chain 3.51
Q32LG3 Malate dehydrogenase, mitochondrial 3.43
O46521 Cytochrome b245 light chain 3.40
Q58CQ2 Actin-related protein 2/3 complex subunit 1B 3.32
P61157 Actin-related protein 3 3.23
Q3SYV4 Adenylyl cyclase-associated protein 1 3.19
P46193 Annexin A1 3.16
P00829 ATP synthase subunit beta, mitochondrial 3.13
Q3T0E5 Adipocyte plasma membrane-associated protein 3.10
Q5E9B1 L-Lactate dehydrogenase B chain 3.05
Q0VCG9 Pentraxin-related protein PTX3 3.05
Q28125 Intercellular adhesion molecule 3 3.00
O95498 Vascular noninflammatory molecule 2 2.95
Q9UM07 Protein-arginine deiminase type 4 2.95
Q32LP0 Fermitin family homolog 3 2.89
P19483 ATP synthase subunit alpha, mitochondrial 2.88
P11678 Eosinophil peroxidase 2.84
Q3UP87 Neutrophil elastase 2.78
Q13349 Integrin alpha-D 2.78
P02313 Nonhistone chromosomal protein HMG-17 2.78
P10096 Glyceraldehyde-3-phosphate dehydrogenase 2.73
P05044 Sorcin 2.72
Q9XT27 Ceruloplasmin 2.72
Q63610 Tropomyosin alpha-3 chain 2.66
Q99N16 Leukotriene-B4 omega-hydroxylase 2 2.60
P52272 Heterogeneous nuclear ribonucleoprotein M 2.52
O00160 Unconventional myosin If 2.52
P40673 High-mobility-group protein B2 2.52
Q0VCW4 L-Serine dehydratase/L-threonine deaminase 2.45
O77774 Neutrophil cytosol factor 1 2.45
O77775 Neutrophil cytosol factor 2 2.45
A7VJC2 Heterogeneous nuclear ribonucleoproteins A2/B1 2.45
P19134 Serotransferrin 2.38
Q14739 Lamin B receptor 2.37
Q8IZW8 Tensin 4 2.37
P35246 Pulmonary surfactant-associated protein D 2.37
Q5R7W2 Phosphate carrier protein, mitochondrial 2.37
O15144 Actin-related protein 2/3 complex subunit 2 2.33
TABLE 3 (Continued)
Accession no.b Description RSC
Q8BJS4 SUN domain-containing protein 2 2.29
A7MB62 Actin-related protein 2 2.28
P04157 Receptor-type tyrosine-protein phosphatase C 2.21
Q96KK5 Histone H2A type 1-H 2.20
P21796 Voltage-dependent anion-selective channel
protein 1
2.17
O35737 Heterogeneous nuclear ribonucleoprotein H 2.12
Q3SYX9 Actin-related protein 2/3 complex subunit 5 2.12
Q3TRM8 Hexokinase 3 2.12
P32007 ADP/ATP translocase 3 2.10
P29350 Tyrosine-protein phosphatase non-receptor
type 6
2.03
Q8VC88 Grancalcin 2.03
P12725 Alpha-1-antiproteinase 2.02
Q9GL30 Phospholipase B-like 1 2.02
Q68CQ1 Maestro heat-like repeat-containing protein
family member 7
2.02
Q13838 Spliceosome RNA helicase DDX39B 2.02
P54230 Cathelicidin 1 1.97
P02584 Profilin 1 1.96
O75131 Copine 3 1.92
Q56JZ9 Glia maturation factor gamma 1.92
P85521 Scavenger receptor cysteine-rich type 1 protein
M130
1.92
Q2KJD0 Tubulin beta-5 chain 1.92
P28782 Protein S100A8 1.86
P02253 Histone H1.2 1.82
P30358 Arachidonate 5-lipoxygenase-activating protein 1.81
Q5MIB5 Glycogen phosphorylase, liver form 1.81
O02849 Protein-arginine deiminase type 3 1.81
D3ZZL9 GRIP and coiled-coil domain-containing
protein 2
1.81
Q3T149 Heat shock protein beta-1 1.78
P13796 Plastin 2 1.76
Q3T035 Actin-related protein 2/3 complex subunit 3 1.75
Q95218 Deleted in malignant brain tumor 1 protein 1.73
P41976 Superoxide dismutase [Mn], mitochondrial 1.72
P48975 Actin, cytoplasmic 1 1.69
Q5E9J1 Heterogeneous nuclear ribonucleoprotein F 1.69
A4IF97 Myosin regulatory light chain 12B 1.69
P50415 Cathelicidin 3 1.67
P81947 Tubulin alpha-1B chain 1.65
Q3ZBV8 Threonine-tRNA ligase, cytoplasmic 1.63
Q8BFZ3 Beta-actin-like protein 2 1.60
P62803 Histone H4 1.59
P09769 Tyrosine-protein kinase Fgr 1.58
P17453 Bactericidal permeability-increasing protein 1.56
P17697 Clusterin 1.55
Q148J6 Actin-related protein 2/3 complex subunit 4 1.55
P47791 Glutathione reductase, mitochondrial 1.53
A7E3Q8 Plastin 3 1.52
a Significant (P 0.05, beta-binomial test) increase in abundance (RSC 1.5) after S.
uberis infection (third day after the second inoculation) according to LTQ-Orbitrap
GeLC-MS/MS.
b Accession number in the Uniprot database.
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As expected, the control animal showed no reactivity for either
S100A9 or cathelicidin (Fig. 6A, left), while mammary tissue from
inoculated half udders showed a strong and specific reactivity for
both S100A9 and cathelicidin, localized mainly within the milk
duct lumens (Fig. 6A, right). The most interesting information
emerged when uninoculated half udders of infected animals were
tested (Fig. 6A, middle, and B). Here, a distinctly positive signal
was observed in cells lining the milk ducts, suggesting that epithe-
lial cells are likely producing both S100A9 and cathelicidin. In
addition, the two proteins showed different patterns of reactivity:
S100A9 was more diffusely distributed within the cytoplasm,
while cathelicidin displayed a granular staining. In several occur-
rences, positive staining was observed in the duct lumen inside
globular formations within milk, possibly corresponding to pro-
teins localized within MFGs (Fig. 6B, top right).
In order to further investigate the cellular origin of S100A9 and
cathelicidin, a colocalization experiment was carried out by con-
focal microscopy with antibodies against the two proteins and
against epithelial cell, neutrophil, and macrophage markers. Fig-
ure 7 reports the reactivity of S100A9 and cathelicidin in MECs
(Fig. 7A), in neutrophils (Fig. 7B), and in macrophages (Fig. 7C).
Cell nuclei are colored blue (Hoechst staining), S100A9 and cathe-
licidin are colored red, and cell markers are colored green.
As illustrated in Fig. 7A (left and middle), S100A9 and catheli-
cidin were clearly expressed in MECs of neighboring, uninocu-
lated half udders, with a positive signal (red) located in pancytok-
eratin-positive cells (green). Notably, both signals were located in
cells lining the lactiferous ducts. On the other hand, when inocu-
lated half udders were tested, the S100A9 and cathelicidin signals
were mainly located in the milk duct lumens (Fig. 7A, right). This
is most likely a consequence of acute mastitis, marked by protein
secretion, tissue disintegration, and massive neutrophil recruit-
ment. Accordingly, in neutrophils, a positive signal for the two
proteins was observed in both the uninoculated and inoculated
halves, mainly outside and inside alveoli, respectively (Fig. 7B).
Neither S100A9 nor cathelicidin was detected in macrophages
(Fig. 7C).
Detection of S. uberis in milk and mammary tissues. The
detection of specific immunological staining for S100A9 and
cathelicidin in uninoculated half udders suggested dissemination
of the S. uberis infection from the neighboring inoculated half
udder, an occurrence reported in other experimental infections
with environmental pathogens (40). To test this hypothesis, all
milk and mammary tissue samples collected during the study were
tested by PCR for S. uberis. Results are reported in Table 4. All
animals, including the uninfected control, were found to be neg-
ative preinoculation (D0) and 5 days after the first inoculation
(5DIi). Five days after the second inoculation (5DIIi), all inoc-
ulated halves were found to be positive for S. uberis (Table 4).
The results of milk PCR were in accordance with those of bac-
terial cultures, since positivity for S. uberis was detected only
after the second inoculation. Mammary tissue PCR was posi-
tive for S. uberis in both the inoculated and uninoculated
halves, supporting transmission of the pathogen from the in-
oculated half udder to the neighboring one. In the control an-
imal, milk and tissue PCR remained negative throughout the
infection experiment.
The transmission of S. uberis to the uninoculated half udder of
infected animals was also confirmed by fluorescent in situ hybrid-
ization (FISH). In fact, positive signals corresponding to S. uberis
were detected in both halves, as shown in Fig. 8. In the inoculated
half udder, bacteria were mainly localized in macrophages within
the milk duct lumens, while in the neighboring half, they were
mainly located in the proximity of MECs. In the control animal,
FIG 5 Normalized spectral abundance factors (NSAFs) of selected antimicrobial proteins. Bars indicate the abundance and standard deviation abundance of
antimicrobial proteins in the milk fat fraction before and after infection. Proteins having direct antimicrobial functions according to the Uniprot Knowledgebase
and showing statistically significant changes in abundance (RSC) between the two conditions (Table 3) are reported.
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mammary tissue from both udder halves was also almost com-
pletely negative for S. uberis by FISH, excepted for few scattered
spots of reactivity.
Time course of S100A9 and cathelicidin release byMECs in-
ferred fromMFG proteomics. In order to validate the results ob-
tained with the proteomics analysis and the immunological and
molecular approaches and to assess the kinetics of S100A9 and
cathelicidin expression in MECs, a Western immunoblotting ex-
periment was carried out on milk samples collected over the
course of the experimental infection. Figure 9 reports the total
protein profiles of MFGPs (Fig. 9A) and the reactivity for S100A9
and cathelicidin (Fig. 9B) observed in inoculated and uninocu-
lated half udders, as well as in the negative-control animal. Sam-
ples collected preinoculation (D0), from the 1st to the 5th days
after the first inoculation (1DIi to 5DIi), and on the 1st, 3rd, and
6th days after the second inoculation (1DIIi, 3DIIi, and 6DIIi) were
tested.
Significant alterations in the total protein pattern were already
evident 1 day after the first inoculation (1DIi), increasing in inten-
sity and peaking at 2DIi, and then slowly reverting to the initial
condition at day 5DIi. Following the second inoculation, the pro-
tein profile underwent an immediate and dramatic alteration,
which was maintained throughout the 6 days of infection (1DIIi to
6DIIi) The same behavior in the reactivity of S100A9 and catheli-
cidin was observed by Western immunoblotting (Fig. 9B); an in-
crease in the abundance of both proteins started at day 1 of the first
infection (1DIi), decreased after day 3 (3DIi), and then rose again
at day 1 after the second inoculation (3DIIi). Remarkably, the same
pattern of reactivity, although with a weaker intensity, was ob-
served when the neighboring, uninoculated half udders were
tested, indicating the rapid increase of these proteins following an
inflammatory stimulus. Both proteins were always undetectable
in milk collected from the control animal.
DISCUSSION
In this study, we investigated the events taking place in the mam-
mary gland following experimental infection with S. uberis, a com-
mon etiologic agent of mastitis in sheep. S. uberis is considered an
environmental pathogen since it is commonly isolated from the
environment, milking machines, milkers’ hands, and the skin of
the teats. Mastitis may therefore originate when the mammary
gland is exposed to higher loads of this bacterial species. Inflam-
FIG 6 Immunohistochemical analysis of mammary tissues. (A) Reactivity of mammary tissues from the indicated animals for pancytokeratin, S100A9, and
cathelicidin. (B) Reactivity of mammary tissues from the uninoculated half udders of infected animals for S100A9 and cathelicidin. All animals included in the
experiment were tested in replicate experiments. Arrows, focal points of reactivity.
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FIG 7 Immune colocalization analysis of mammary tissues. The reactivities of mammary tissues to antibodies against S100A9 and cathelicidin (green signals),
together with cell-type-specific antibodies (red signals), are shown. (A) Epithelial cells; (B) neutrophils; (C) macrophages.
Addis et al.
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mation triggered by S. uberis may occur without clinical signs and
spontaneously resolve, or it may become chronic. In order to in-
vestigate these heterogeneous balances between infecting bacteria
and host innate immune response, we have conceived a two-step
infection in one udder half, where each individual received two
different bacterial inocula, with a 1-log10-unit increase in the bac-
terial load between the two inocula, 1 week apart. As expected, the
first, lower dose of 1 106 CFU did not cause any clinical sign of
mastitis, nor could S. uberis be isolated in culture or detected in
milk by PCR. On the other hand, a second inoculum of 2  107
CFU led to the manifestation of clinical mastitis and pathogen
detection in milk. This is in agreement with the observations of
Lasagno et al. (41). These authors reported that inoculation with
S. uberis at between 8.0  102 CFU and 2.4  106 CFU was not
sufficient to induce clinical mastitis in dairy goats; only higher
loads of S. uberis (1.7 108 CFU) enabled the induction of mild
clinical manifestations (41). This model of infection therefore al-
lowed us to evaluate the host immune defense in a framework of
infection control and quick bacterial eradication and under a sub-
sequent condition of clinical mastitis with bacterial survival and
persistence. Furthermore, in this model of infection, bacterial per-
sistence and replication might easily allow the transmission of
infection to the contralateral udder half. Previous studies have
reported the frequent occurrence of pathogen dissemination from
infected udder halves to contralateral uninfected ones, where in-
fection is established without evidence of clinical signs (40, 42).
Indeed, this event occurred during our experimental infection of
sheep with S. uberis, probably at the time of the second bacterial
infection, with the inoculated udder half modeling for clinical
mastitis and the contralateral, uninoculated udder half modeling
for a subclinical infection, as demonstrated by PCR, fluorescent in
situ hybridization, and changes in the proteomic profile of MFGs.
This favorable occurrence enabled us to investigate the phenom-
ena that take place during subclinical mastitis: (i) the role played
by MECs as the first line of defense against microbes entering the
mammary gland, (ii) the response of the mammary gland to small
bacterial loads, and (iii) the mediators released in milk when ani-
mals are carrying the bacteria but are not showing any evident
clinical signs.
To assess the changes occurring in the actively secreting mam-
mary epithelium and to specifically probe the contents of lactating
cells, we used MFGs as a means to investigate protein expression
levels within MECs. The use of MFGs to investigate the changes
occurring in MECs upon exposure to bacterial pathogens has
proven successful in a previous study on natural infection of sheep
by Mycoplasma agalactiae (18). The usefulness of the MFG as a
TABLE 4 Results obtained by milk and tissue PCR for detection of S.
uberis
Sample
Time of
sample
collection Half udder tested PCR result
Milk sample_1 D0 Uninoculated 
D0 Inoculated 
Milk sample_2 D0 Uninoculated 
D0 Inoculated 
Milk sample_3 D0 Uninoculated 
D0 Inoculated 
Milk sample_K D0 Uninoculated 
Milk sample_1 5DIi Uninoculated 
5DIi Inoculated 
Milk sample_2 5DIi Uninoculated 
5DIi Inoculated 
Milk sample_3 5DIi Uninoculated 
5DIi Inoculated 
Milk sample_K 5DIi Uninoculated 
Milk sample_1 3DIIi Uninoculated 
3DIIi Inoculated 
Milk sample_2 3DIIi Uninoculated 
3DIIi Inoculated 
Milk sample_3 3DIIi Uninoculated 
3DIIi Inoculated 
Milk sample_K 3DIIi Uninoculated 
Breast tissue sample_1 Postmortem Uninoculated 
Postmortem Inoculated 
Breast tissue sample_2 Postmortem Uninoculated 
Postmortem Inoculated 
Breast tissue sample_3 Postmortem Uninoculated 
Postmortem Inoculated 
Breast tissue sample_K Postmortem Uninoculated 
FIG 8 Results of FISH for S. uberis. The reactivity obtained with an S. uberis-specific probe is shown in the mammary tissues of the control sheep, the
uninoculated half udders of infected animals, and the inoculated half udders of infected animals.
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surrogate of the lactating cell is also corroborated by the work of
Brenaut et al. (43), who exploited MFGs as a main source of mam-
mary RNAs to evaluate the dynamics of the global transcriptional
response in MECs during bacterial infection. In fact, MFGs orig-
inate from the MEC as vesicles released from the apical part of the
polarized secretory epithelium and, during this process, carry por-
tions of the lactating cell cytoplasm with them (44). This phenom-
enon presents with various intensities in different animal species,
and it is believed to be more prominent in small ruminants than in
bovines (31, 32, 45, 46).
In the work presented here, the MFG proteomics approach
provided results in line with those obtained with M. agalactiae.
Upon infection with S. uberis, the fat fraction was strongly en-
riched in, among other proteins, lactotransferrin, cathelicidins,
and calprotectin, according to both DIGE and GeLC-MS/MS, to-
gether with several other acute-phase reactants, including hapto-
globin, myeloperoxidase, and leukocyte elastase inhibitor, identi-
fied by means of the latter approach (Table 3; Fig. 5).
These proteins are mainly released by immune cells as part of
the innate response against pathogens (4); however, the role of
epithelial cells as the first line of defense, especially in secretory
epithelia, is gaining importance. Lactotransferrin is an iron-bind-
ing protein mainly synthesized by MECs and, to a lesser extent, by
neutrophils (47), having antibacterial, immune-modulating, anti-
inflammatory, and antioxidant activity (48, 49). Haptoglobin is
found to be increased in plasma and in milk in clinical mastitis and
in chronic subclinical mastitis, together with amyloid protein A
(24), and several studies indicated that one of the main sources of
these two proteins in milk might be MECs (50–52). S100A9 and
S100A8 are mainly expressed in the cytoplasm of neutrophils and
monocytes but also in activated endothelial and epithelial cells
(53–59). As a consequence, S100 proteins are also being proposed
to be markers for several inflammatory diseases. Alone or in asso-
ciation as calprotectin (54), S100A8 and S100A9 exert strong pro-
inflammatory and chemotactic activities (60) by promoting leu-
kocyte recruitment (61, 62). In addition, the calprotectin
heterodimer exerts direct antimicrobial functions by sequestering
zinc and manganese (59, 63–66). The concerted increase in abun-
dance of the two monomers S100A9 and S100A8 observed in
MFGs upon infection with S. uberis (Table 3 and Fig. 5) and M.
agalactiae (18), together with the detection of S100A9 in MECs by
IHC, is strongly suggestive of their ability to produce and release
the calprotectin heterodimer.
Cathelicidins are a family of antimicrobial peptides (AMPs)
FIG 9 Time course of the MFGP profile and of S100A9 and cathelicidin reactivity over the course of infection. (A). Total MFGP profile over the course of
infection, starting with preinoculation (D0) and continuing to the last day of the second inoculation with S. uberis (6DIIi). (B) Reactivity of S100A9 and
cathelicidin in inoculated and uninoculated half udders of infected animals and in control animals. Lanes M, molecular mass markers.
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that act as multifunctional effectors in innate immunity (4, 25, 67,
68). Cathelicidins are synthesized as preproproteins and are
cleaved by proteases (such as serine proteases, proteinase 3, elas-
tase, and kallikrein) to generate the cathelin domain and a C-ter-
minal AMP (LL-37 in humans) (69, 70). These domains have
antimicrobial properties, with the cathelin domain possessing
chemotactic and proinflammatory activity and the AMP exploit-
ing a direct lytic activity against bacteria (71, 72). These molecules
are the primary constituents of the neutrophil secondary granule,
and very high expression levels have been reported under different
inflammatory conditions (73). This is in agreement with the
strongly positive signal observed for cathelicidin in neutrophils of
the inoculated udder halves by both IHC and immune colocaliza-
tion (Fig. 6A and Fig. 7).
In recent years, cathelicidins have increasingly been detected in
other cell types (epithelial cells, mast cells, lymphocytes, and ke-
ratinocytes), as well as in a wide variety of tissues (oral cavity, skin,
intestine, lungs, cervix, etc.) and body fluids (plasma, breast milk,
saliva, gastric juice, semen, sweat, and bronchoalveolar fluid) (74).
Concerning MECs, the production of cathelicidins and other pro-
inflammatory/chemotactic mediators has been investigated al-
most exclusively by means of gene expression approaches either
during the course of bovine mastitis or through the use of cultured
mammary cells, providing contrasting results (75, 76). However, a
study evaluating the production dynamics of cathelicidin release
by mammary epithelial cells in humans demonstrated that cathe-
licidin mRNA is already present in cells and exposure to a bacterial
pathogen triggers translation and secretion, accompanied by a net
decrease in cathelicidin mRNA levels due to its concomitant deg-
radation (67); this might explain the contrasting results obtained
by some investigators attempting to assess the ability of MECs to
produce cathelicidin and other mediators of innate immunity.
Therefore, the choice of a proteomic approach can help to circum-
vent this problem by directly assessing the protein levels and en-
abling their localization within the cells of an infected mammary
gland.
In our previous work on the proteomics of milk secretions
collected from sheep naturally infected by M. agalactiae, the mas-
sive increase of antimicrobial and immune defense proteins
within MFGs was strongly suggestive of their MEC origin (18).
Here, the ability of MECs to produce cathelicidin and calprotectin
in vivowas further demonstrated with the same indirect approach,
provided by the proteomic analysis of MFGs, but it was further
reinforced by means of a direct approach, that is, IHC and im-
mune colocalization in infected mammary tissues. In addition,
this again supports the use of MFGs as a noninvasive model to
study what is happening within MECs in vivo, as they are able to
provide information about the changes that occur in these cells
upon exposure to pathogens. In fact, it can be speculated that these
cells also have the potential to produce other immune and anti-
microbial proteins, as the proteomic results obtained on the MFG
fraction might suggest.
Here, IHC and immune colocalization (Fig. 6 and 7) clearly
demonstrated that both S100A9 and cathelicidin are present
within the MEC cytoplasm, as well as in neutrophils, as expected.
In addition, the staining pattern was compatible with their cellular
distribution, since it appeared to be finer and more disperse for
S100A9, which is associated with microtubules in the cytoplasm,
and more granular and compartmentalized for cathelicidin,
which is located within secretory granules. In addition, although
the epithelial layer is compromised, both proteins can also be seen
in association with epithelial cells by immune colocalization in the
acutely mastitic, inoculated half udders. Here, however, the sig-
nificant positivity of neutrophils and their massive recruitment to
the infected site could also be seen, as expected from the known
ability of these cells to produce and release AMPs and acute-
phase-response proteins, as well as from the strong chemoattrac-
tant activity exerted by these proteins at the site of infection (77).
Conversely, macrophages remained negative in all samples and
under all conditions examined.
The most interesting results about the ability of MECs to pro-
duce these innate immunity mediators emerged from analysis of
tissue and secretions from the uninoculated half udder. In fact, as
mentioned above, PCR and FISH confirmed that transfer of the
bacterial infection from the inoculated half udder to the neighbor-
ing one occurred, creating conditions that were similar to those
occurring in a natural subclinical infection. This leads to specula-
tion on the role that these two proteins may have in early detection
and in prediction of infection; in fact, it is now known that both
represent valuable markers of inflammation, as their presence has
been detected in a number of inflammatory conditions.
The kinetic assessment of cathelicidin and S100A9 release in
milk from inoculated udder halves showed that these proteins are
produced immediately upon exposure to the pathogen. This trend
is consistent with that previously described by Smolenski et al.
(78), who observed an immediate increase of cathelicidin in milk
after intramammary inoculation of different pathogens into lac-
tating cows. In both cases, strong and specific signals were ob-
served 24 h after the first inoculation. The signals peaked after 48
h and then reverted to the initial conditions when infection was
not established or peaked and were maintained at elevated levels
when infection occurred. Although milk PCR and bacterial cul-
ture remained negative after the first low-dose bacterial inocula-
tion, as well as in the cross-infected, uninoculated half udder, the
presence of proinflammatory and antimicrobial proteins was
clearly detectable. It is likely that MECs are immediately reacting
to bacterial cells by producing and releasing proinflammatory and
antimicrobial proteins that can be detected in milk as an indicator
of inflammation. In addition, positivity for these markers reverts
within a few days if infection is not established, while it persists at
high levels when infection occurs. These results support a poten-
tial significant role of cathelicidin and the calprotectin subunit
S100A9 in predicting the presence of a pathogen in the mammary
epithelium regardless of clinical symptoms, suggesting their use-
fulness as tools for the detection of various disease states, includ-
ing subclinical mastitis.
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